New Initiative to Re-assess the Efficacy of Antimicrobial Drugs Used as Antimicrobial Growth Promotants (AGPs) There is some evidence that the use of antimicrobial drugs for growth promotion (AGPs) that were approved in the past decades at their recommended dose levels may no longer be effective.
Santé Canada consultera les intervenants sur les lignes directrices aussitôt que possible en 2006. Le Comité directeur du VICH a également avalisé la LD 39 du VICH – Quality Specifications – Test Procedures and Acceptance Criteria for new Veterinary Drug Substances and New Medicinal Products: